ÌÇÐÄÆƽâ°æ

As of 2024, GSK (GlaxoSmithKline) - with 3.72 - had the second-highest total score. It was the first time in 16 years that GSK was not ranked first. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.